Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
MTOR
REST API REST API
Homo sapiens
MTOR is differentially expressed in 166 experiments: 76 organism parts: testis, kidney, ... (74 more);, 130 disease states: normal, acute promyelocytic leukemia, ... (128 more);, 45 cell types 222 cell lines 13 compound treatments and 57 other conditions.
Synonyms RAPT1, FLJ44809, FRAP1, FRAP2, FRAP, RAFT1
Orthologs MTOR (Bos taurus)   mtor (Danio rerio)   Mtor (Rattus norvegicus)   TOR1 (Saccharomyces cerevisiae)   ENSCING00000001460 (Ciona intestinalis)   Mtor (Mus musculus)   MTOR (Gallus gallus)   Tor (Drosophila melanogaster)   MTOR (Canis familiaris)   XB-GENE-994583 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term negative regulation of macroautophagy, endomembrane system, cytosol, phosphorylation, endoplasmic reticulum, protein binding, positive regulation of translation, phosphotransferase activity, alcohol group as acceptor, cytoplasm, protein catabolic process, peptidyl-serine phosphorylation, membrane, lysosome, Golgi membrane, Golgi apparatus, regulation of protein kinase activity, insulin receptor signaling pathway, protein domain specific binding, fibroblast growth factor receptor signaling pathway, mitochondrial outer membrane, cell growth, soluble fraction, positive regulation of actin filament polymerization, response to nutrient, ATP binding, growth, transferase activity, transferring phosphorus-containing groups, regulation of response to food, nucleus, dendrite, germ cell development, negative regulation of autophagy, nucleotide binding, kinase activity, protein serine/threonine kinase activity, phosphoprotein binding, binding, regulation of actin cytoskeleton organization, cell projection organization, peptidyl-threonine phosphorylation, endoplasmic reticulum membrane, ribosome binding, signal transduction, negative regulation of cell size, mitochondrion, neuronal cell body, TOR signaling cascade, positive regulation of lamellipodium assembly, ruffle organization, positive regulation of peptidyl-tyrosine phosphorylation, cellular response to hypoxia, TORC2 complex, TORC1 complex, cellular response to nutrient levels, regulation of Rac GTPase activity, positive regulation of stress fiber assembly, response to amino acid stimulus, PML body, response to insulin stimulus, regulation of carbohydrate metabolic process, regulation of glycogen biosynthetic process, positive regulation of transcription from RNA polymerase III promoter, nerve growth factor receptor signaling pathway, positive regulation of endothelial cell proliferation, T cell costimulation, positive regulation of protein kinase B signaling cascade, regulation of carbohydrate utilization, regulation of fatty acid beta-oxidation, negative regulation of NFAT protein import into nucleus, protein autophosphorylation, protein phosphorylation, positive regulation of protein phosphorylation, phosphatidylinositol-mediated signaling, phosphatidylinositol 3-kinase complex, RNA polymerase III type 2 promoter DNA binding, TFIIIC-class transcription factor binding, RNA polymerase III type 1 promoter DNA binding, RNA polymerase III type 3 promoter DNA binding, mTOR-FKBP12-rapamycin complex
InterPro Term PIK_FAT, PIK-rel_kinase_FAT, FKBP_rapamycin-assoc_FKBP12-bd, FATC, PI3/4_kinase_cat, DUF3385_TOR
UniProt Accession Q96QW8, B1AKP8, B1AKQ2, P42345, F5GYA6
Search EB-eye ENSG00000198793
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-MTAB-24, E-MTAB-25, E-GEOD-1563, ... (16 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-1880, E-MEXP-1006, E-GEOD-19639, E-GEOD-18005, E-GEOD-19397, ... (24 experiments)

Factor Value U/D Experiments
A549
1
2
E-GEOD-6013, E-GEOD-3202
MCF-7
2
E-GEOD-3529, E-GEOD-20081
MOLT4
2
E-MTAB-62, E-MTAB-37
SiHa
1
E-MTAB-37
MS-1
1
E-MTAB-62
SW1353
1
E-MTAB-37
216 more value(s).


Cell type

studied in E-GEOD-18811, E-AFMX-5, E-TABM-40, E-MTAB-25, E-GEOD-20033, ... (23 experiments)

Factor Value U/D Experiments
2
E-TABM-130, E-TABM-145
adipose stem cells derived from adult human donor
1
E-GEOD-20033
skin substitute
1
E-GEOD-3204
monolayer
1
E-GEOD-4219
leydig cell
1
E-MTAB-25
adult choroid from 76 y.o. donor
1
E-GEOD-18811
39 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-MEXP-25, E-GEOD-2466, E-GEOD-22148, ... (35 experiments)

Factor Value U/D Experiments
acute promyelocytic leukemia
3
E-MTAB-62, E-GEOD-995, E-GEOD-96
colon carcinoma
2
E-MTAB-37, E-MTAB-62
schwannoma
1
E-MTAB-62
KSHV infection
1
E-MEXP-66
infectious colitis
1
E-GEOD-6731
baseline uninfected
1
E-GEOD-5418
124 more value(s).


Compound treatment

studied in E-MEXP-1601, E-MEXP-1269, E-GEOD-5258, E-GEOD-3284, E-GEOD-412, ... (11 experiments)

Factor Value U/D Experiments
none
1
5
E-GEOD-412, E-GEOD-2649, E-GEOD-6431, E-GEOD-995, E-MEXP-1601, ... (6 experiments)
nocodazole
1
E-GEOD-6431
bacterial endotoxin
1
1
E-GEOD-3284
estradiol
4
1
E-GEOD-20081
5-aza-2'-deoxycytidine + trichostatin A
1
1
E-MEXP-1269
not specified
1
E-GEOD-20081
7 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical info
studied in E-TABM-302, E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-19348, ... (10 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-MEXP-2359, E-MTAB-62

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-22148, E-TABM-147, E-GEOD-21887 ... (5 experiments)

Environmental stress
studied in E-GEOD-3720

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-GEOD-20847

Genotype
studied in E-GEOD-2466, E-GEOD-18005, E-GEOD-1153, E-GEOD-17347, E-MEXP-1403 ... (5 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-MEXP-1446, E-MEXP-1741, E-MEXP-2146

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-MTAB-197, E-GEOD-2466, E-GEOD-1926, E-GEOD-19330, E-GEOD-19519, ... (20 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-12254, E-MEXP-561, E-GEOD-980

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-455, E-MEXP-958

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-GEOD-426, E-TABM-84

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-19703, E-GEOD-22152, E-GEOD-22309, E-GEOD-21750, E-GEOD-1657, ... (7 experiments)

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-19246

Replicate
studied in E-GEOD-10896

RNAi
studied in E-GEOD-12438, E-MEXP-1509, E-GEOD-3697, E-MEXP-1857

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-2466

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-GEOD-1926

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Vehicle
studied in E-GEOD-5258

Processing time: 0.516 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM